Australian firm: Pig cell insulin treatment approved for sale in Russia

Australian biotechnology firm Living Cell Technologies Ltd has won approval from Russia to sell its Type 1 diabetes treatment using insulin-producing cells from pigs, the company said on Friday, sending its shares up by a quarter.

Russia was the first major industrialized nation to approve the sale of the new treatment, said LCT. (Reuters)